Huadong Medicine Co Ltd 2024 SR
The report highlights Huadong Medicine's 2024 performance across its four major business segments: pharmaceutical industry, pharmaceutical business, aesthetic medicine, and industrial microbiology. Key achievements include the market launch of innovative drugs such as Elahere and Arcalyst, and the approval of Sailexin. The company strengthened its ESG governance through a three-tier structure and conducted a double materiality analysis. Environmental initiatives focused on green operations, including the purchase of 15,000 Green Electricity Certificates and the generation of over 3.2 million kWh from its PV plant. Socially, the company invested RMB 2.678 billion in R&D and contributed RMB 105 million to public welfare.
Company: Huadong Medicine Co Ltd
Sector: Health Care
Country: China
Year: 2024
Type: SR
Pages: 62
Huadong Medicine Co Ltd
ESG Report
The report highlights Huadong Medicine's 2024 performance across its four major business segments: pharmaceutical industry, pharmaceutical business, aesthetic medicine, and industrial microbiology. Key achievements include the market launch of innovative drugs such as Elahere and Arcalyst, and the approval of Sailexin. The company strengthened its ESG governance through a three-tier structure and conducted a double materiality analysis. Environmental initiatives focused on green operations, including the purchase of 15,000 Green Electricity Certificates and the generation of over 3.2 million kWh from its PV plant. Socially, the company invested RMB 2.678 billion in R&D and contributed RMB 105 million to public welfare.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Apr 1, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Employees